Results 171 to 180 of about 2,940,629 (293)

[Biomechanical study of three-dimensional printed filler block design in open wedge high tibial osteotomy]. [PDF]

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
Zhang J, Zhang J, Guo L, Chen S, Jin Z, Chen Z.   +5 more
europepmc   +1 more source

Aphasia rehabilitation based on mirror neuron theory: a randomized-block-design study of neuropsychology and functional magnetic resonance imaging. [PDF]

Neural Regen Res, 2019
Chen WL, Ye Q, Zhang SC, Xia Y, Yang X, Yuan TF, Shan CL, Li JA.   +7 more
europepmc   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Is grid therapy useful for all tumors and every grid block design? [PDF]

J Appl Clin Med Phys, 2016
Gholami S, Nedaie HA, Longo F, Ay MR, Wright S, Meigooni AS.   +5 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Does higher sampling rate (multiband + SENSE) improve group statistics - An example from social neuroscience block design at 3T.

Neuroimage, 2020
Bhandari R, Kirilina E, Caan M, Suttrup J, De Sanctis T, De Angelis L, Keysers C, Gazzola V.   +7 more
europepmc   +1 more source

Comparison of fMRI analysis methods for heterogeneous BOLD responses in block design studies. [PDF]

Neuroimage, 2017
Liu J, Duffy BA, Bernal-Casas D, Fang Z, Lee JH.   +4 more
europepmc   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

Comparison of Functional Connectivity Estimated from Concatenated Task-State Data from Block-Design Paradigm with That of Continuous Task. [PDF]

Comput Math Methods Med, 2017
Zhu Y, Cheng L, He N, Yang Y, Ling H, Ayaz H, Tong S, Sun J, Fu Y.   +8 more
europepmc   +1 more source